Serological markers, viral RNA and genotype of hepatitis delta virus in HBs antigen positive Tunisian patients;Marqueurs sérologiques, ARN viral et génotype du virus de l'hépatite delta chez des patients tunisiens antigène HBs positifs

Pathologie Biologie

Volumn 57, Issue 7-8, 2009, Pages 518-523

  Djebbi, A ^a   Rebai, W K ^a   Bahri, O ^a   Hogga, N ^a   Sadraoui, A ^a   Triki, H ^a  

^a PASTEUR INSTITUTE OF TUNIS   (Tunisia)

Author keywords

Genotype; HDV; PCR; Seroprevalence

Indexed keywords

HEPATITIS B ANTIGEN; HEPATITIS B(E) ANTIGEN; HEPATITIS DELTA ANTIGEN; VIRUS ANTIBODY; VIRUS DNA; VIRUS RNA;

ARTICLE; DELTA AGENT HEPATITIS; DISEASE MARKER; DNA DETERMINATION; ENDEMIC DISEASE; FEMALE; GENE AMPLIFICATION; GENOTYPE; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS DELTA VIRUS; HUMAN; MAJOR CLINICAL STUDY; MALE; MOLECULAR EPIDEMIOLOGY; NONHUMAN; NUCLEOTIDE SEQUENCE; PREVALENCE; RNA ANALYSIS; SEROLOGY; SYMPTOM; TUNISIA; VIRUS CARRIER; VIRUS REPLICATION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; FEMALE; GENE AMPLIFICATION; HEPATITIS B; HEPATITIS B ANTIGENS; HEPATITIS B VIRUS; HEPATITIS D; HEPATITIS DELTA VIRUS; HUMANS; MALE; MIDDLE AGED; RNA, VIRAL; SEROEPIDEMIOLOGIC STUDIES; TUNISIA; YOUNG ADULT;

EID: 71849083485     PISSN: 03698114     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.patbio.2008.09.010     Document Type: Article

References (29)

1. Rizzetto M., Purcell R.H., and Gerin J.T. Epidemiology of HBV associated delta agent: geographical distribution of anti-delta and prevalence in polytransfused HBs Ag carriers. Lancet 1 (1980) 1215-1219
2. Houissa R., Gharbi Y., Coursaget P., and El Goulli N. Épidémiologie de l'hépatite B en Tunisie. Arch Inst Pasteur Tunis 65 (1988) 53-58
3. Jammeli M., Said S., Gaumer B., Sabbagh K., Yang C., Pillot J., et al. Contribution à l'étude de l'hépatite B dans la région de Sousse (Tunisie). Arch Inst Pasteur Tunis 59 (1982) 495-509
4. Triki H., Ben Slimane S., Ben Mami N., Sakka T., Ben Ammar A., and Dallagi K. High circulation of hepatitis B virus (HBV) precore mutants in Tunisia, North Africa. Epidemiol Infec 125 (2000) 169-174
5. Triki H., Said N., Ben Salah A., Arrouji A., Ben Ahmed F., Bouguerra A., et al. Seroepidemiology of hepatitis B, C and delta viruses in Tunisia. Trans R Soc Trop Med Hyg 91 (1997) 11-14
6. Bahri O., Cheikh I., Hajji N., Djebbi A., Maamouri N., Sadraoui A., et al. Hepatitis B genotype, precore and core promoter mutants circulating in Tunisia. J Med Virol 78 (2006) 353-357
7. Uchida T., Kaneita Y., Gotoh K., Kanagawa H., Kouyama H., Kawanishi T., et al. Hepatitis C virus is frequently coinfected with serum marker-negative hepatitis B virus: probable replication promotion of the former by the latter as demonstrated by in vitro cotransfection. J Med Virol 52 (1997) 399-405
8. Ivaniushina V., Radjef N., Alexeeva M., Gault E., Semenov S., Salhi M., et al. Hepatitis delta virus genotype I and II cocirculate in an endemic area of Yakutia, Russia. J Gen Virol 82 (2001) 2709-2718
9. Ayed K., Gorgi Y., Najjar T., and Ben Khalifa H. Prévalence des anticorps anti-VHD dans les hépatites aiguës et chroniques en Tunisie. Rev Tun San Mil 1 (1999) 293-295
10. Jenhani F., Ayed K., Gorgi Y., Zoulim F., Pichoud C., and Trepo C. Delta infection in chronic HBs Ag carriers in Tunisia: high prevalence in chronic asymptomatic HBs Ag carriers and in HBs Ag positive cirrhosis. Ann Trop Med Paras 84 (1990) 349-353
11. Makhlouf K. Prévalence des marqueurs du virus delta chez les cirrhotiques et les porteurs de l'Ag HBs en Tunisie [thèse]. Tunis : faculté de médecine de Tunis 1990;1-109.
12. Bezeud A., Rosenswajg M., and Guillin M.C. Evaluation of five hepatitis delta virus marker assays for detection of antigen and antibody. J Clin Microbiol 27 (1989) 2880
13. Dubois F., and Goudeau A. Kinetics of delta antigen and delta antibody in acute delta hepatitis: evaluation with different enzyme immunoassays. J Clin Microbiol 26 (1988) 1339-1342
14. Govindarajan S., Valinluck B., and Lake-Bakkar G. Evaluation of a commercial anti-delta EIA kit for detection of antibodies to hepatitis delta virus. Am J Clin Pathol 95 (1991) 240-241
15. Puig J., and Fields H.A. Development of an enzyme immunoassay using recombinant expressed antigen to detect hepatitis delta virus antibodies. J Clin Microbiol 27 (1989) 2222-2225
16. Shatttock A., and Morris M. Evaluation of commercial enzyme immunoassays for detection of hepatitis delta antigen and anti-hepatitis delta virus (HDV) and immunoglobulin M anti-HDV antibodies. J Clin Microbiol 29 (1999) 1873-1876
17. Gaeta G.B., Stroffolini T., Chiaramonte M., Ascione T., Stornaiuolo G., Lobello S., et al. Chronic hepatitis D: a vanishing disease? An Italian multicenter study. Hepatology 32 (2000) 824-827
18. Deǧertekin H., Yalçin K., and Yakut M. The prevalence of hepatitis delta virus infection in acute and chronic liver diseases in Turkey: an analysis of clinical studies. Turk J Gastroenterol 17 (2006) 25-34
19. Mumtaz K., Hamid S.S., Adil S., Afaq A., Islam M., Abid S., et al. Epidemiology and clinical pattern of hepatitis delta virus infection in Pakistan. J Gastroenterol Hepatol 20 (2005) 1503-1507
20. Makuwa M., Caron M., Souquière S., Malonga-Mouelet G., Mahé A., and Kazanji M. Prevalence and genetic diversity of hepatitis B and delta viruses in pregnant women in Gabon: molecular evidence that hepatitis delta virus clade 8 originates from and is endemic in Central Africa. J Clin Microbiol 46 (2008) 754-756
21. Takahashi M., Nishizawa T., Gotanda Y., Tsuda F., Komatsu F., Kawabata T., et al. High prevalence of antibodies to hepatitis A and E viruses and viremia of hepatitis B, C, and D viruses among apparently healthy populations in Mongolia. Clin Diagn Lab Immunol 11 (2004) 392-398
22. Jardi R., Buti M., Cotrina M., Rodriguez F., Allende H., Esteban R., et al. Determination of hepatitis delta virus RNA by polymerase chain reaction in acute and chronic delta infection. Hepatology 21 (1995) 25-29
23. Chulanov V.P., Shipulin G.A., Schaefer S., and Gerlich W.H. Kinetics of HBV DNA and HBsAg in acute hepatitis B patients with and without coinfection by other hepatitis viruses. J Med Virol 69 (2003) 313-323
24. Viana S., Paraná R., Moreira R.C., Compri A.P., and Macedo V. High prevalence of hepatitis B virus and hepatitis D virus in the western Brazilian Amazon. Am J Trop Med Hyg 73 (2005) 808-814
25. Casey J.L., Brown T.L., Colan E.J., Wignall F.S., and Gerin J.L. A genotype of hepatitis D virus that occurs in northern South America. Proc Natl Acad Sci U S A 90 (1993) 9016-9020
26. Kao J.H., Chen P.J., Lai M.Y., and Chen D.S. Hepatitis D virus genotype in intravenous drug users in Taiwan: decreasing prevalence and lack of correlation with hepatitis B virus genotypes. J Clin Microbiol 40 (2002) 3047-3049
27. Wang T., and Chao M. RNA recombination of hepatitis delta virus in natural mixed-genotype infection and transfected cultured cells. J Virol 79 (2005) 2221-2229
28. Watanabe H., Nagayama K., Enomoto N., Chinzei R., Yamashiro T., Izumi N., et al. Chronic hepatitis delta virus infection with genotype IIb variant is correlated with progressive liver disease. J Gen Virol 84 (2003) 3275-3289
29. Wu J.C., Choo K.B., Chen C.M., Chen T.Z., Huo T.I., and Lee S.D. Genotyping of hepatitis D virus by restriction - fragment length polymorphism and relation to outcome of hepatitis D. Lancet 346 (1995) 939-941